Published in Biochem Pharmacol on June 01, 1979
The efficacy of intensive dietary therapy alone or combined with lovastatin in outpatients with hypercholesterolemia. N Engl J Med (1993) 4.61
Drug treatment of dyslipidemias: practical guidelines for the primary care physician. Heart Dis Stroke (1994) 2.68
The efficacy and six-week tolerability of simvastatin 80 and 160 mg/day. Am J Cardiol (1997) 1.98
Sulfonamide hepatic injury. Review of the literature and report of a case due to sulfamethoxazole. N Engl J Med (1967) 1.97
Ebselen in acute ischemic stroke: a placebo-controlled, double-blind clinical trial. Ebselen Study Group. Stroke (1998) 1.79
Effectiveness and tolerability of ezetimibe in patients with primary hypercholesterolemia: pooled analysis of two phase II studies. Clin Ther (2001) 1.65
An objective assessment of intermittent claudication by near-infrared spectroscopy. Eur J Vasc Surg (1994) 1.64
Efficacy and safety of simvastatin 80 mg/day in hypercholesterolemic patients. The Expanded Dose Simvastatin U.S. Study Group. Am J Cardiol (1998) 1.56
Comparative effects of lovastatin and niacin in primary hypercholesterolemia. A prospective trial. Arch Intern Med (1994) 1.46
The meetabolism of amiloride hydroloride in man. Clin Pharmacol Ther (1969) 1.33
Evaluation of the efficacy, safety, and tolerability of ezetimibe in primary hypercholesterolaemia: a pooled analysis from two controlled phase III clinical studies. Int J Clin Pract (2003) 1.19
Hypoglycemic effects of Teucrium polium. J Ethnopharmacol (1988) 1.12
Absorption and metabolism of L-dopa by the human stomach. Eur J Clin Invest (1971) 1.07
Pesticide mortality. A Jordanian experience. Am J Forensic Med Pathol (1989) 1.07
Clinical complications of corticosteroid therapy. A selected review. Med Clin North Am (1973) 1.06
Ebselen in acute middle cerebral artery occlusion: a placebo-controlled, double-blind clinical trial. Cerebrovasc Dis (1999) 1.02
How useful is the "cocktail approach" for evaluating human hepatic drug metabolizing capacity using cytochrome P450 phenotyping probes in vivo? J Clin Pharm Ther (2003) 0.98
L-dopa treatment failure: explanation and correction. Br Med J (1970) 0.95
Membrane effects of various drugs on isolated rat hepatocytes and erythrocytes. Toxicol Appl Pharmacol (1985) 0.95
Bilateral inguinal hernia repaired by laparoscopic technique: a rare complication of femorofemoral bypass. Surg Endosc (1999) 0.94
Changes of hepatic microsomal oxidative drug metabolizing enzymes in chronic renal failure (CRF) rats by partial nephrectomy. Jpn J Pharmacol (1995) 0.94
Further isolation of a recombinant virus (H1N2, formerly Hsw1N2) from a pig in Japan in 1980. Microbiol Immunol (1983) 0.93
Mechanism of membrane stabilizing and lytic effects of tricyclic antidepressants. Jpn J Pharmacol (1980) 0.92
Expanded Clinical Evaluation of Lovastatin (EXCEL) study results: two-year efficacy and safety follow-up. Am J Cardiol (1994) 0.92
Detection of porcine epidemic diarrhea virus using polymerase chain reaction and comparison of the nucleocapsid protein genes among strains of the virus. J Vet Med Sci (1999) 0.91
Characterization of a 1980-swine recombinant influenza virus possessing H1 hemagglutinin and N2 neuraminidase similar to that of the earliest Hong Kong (H3N2) virus. Arch Virol (1985) 0.91
Near-infrared spectroscopy grades the severity of intermittent claudication in diabetics more accurately than ankle pressure measurement. Br J Surg (2000) 0.91
Blue LED light exposure develops intracellular reactive oxygen species, lipid peroxidation, and subsequent cellular injuries in cultured bovine retinal pigment epithelial cells. Free Radic Res (2013) 0.90
Evaluation of matrix-assisted laser desorption ionization-time of flight mass spectrometry for species identification of Acinetobacter strains isolated from blood cultures. Clin Microbiol Infect (2013) 0.89
Long-term blood cholesterol-lowering effects of a dietary fiber supplement. Am J Prev Med (1999) 0.89
Expanded clinical evaluation of lovastatin (EXCEL) study results: III. Efficacy in modifying lipoproteins and implications for managing patients with moderate hypercholesterolemia. Am J Med (1991) 0.88
The greater omentum is the primary site of neutrophil exudation in peritonitis. J Am Coll Surg (1996) 0.88
Aflaxation B1 hydroxylation by hepatic microsomal preparations from the rhesus monkey. Food Cosmet Toxicol (1975) 0.88
Effects of fenofibrate on plasma lipoproteins in hypercholesterolemia and combined hyperlipidemia. Am J Med (1987) 0.88
Digoxin therapy during T-tube biliary drainage in man. JAMA (1978) 0.86
Toxicity of a hepatotoxic laxative preparation in tissue culture and excretion in bile in man. Clin Pharmacol Ther (1972) 0.86
Protective effect of NaOH-extracted Erysipelothrix rhusiopathiae vaccine in pigs. J Vet Med Sci (1998) 0.86
The instability of isoniazid and acetylisoniazid in frozen plasma. Res Commun Chem Pathol Pharmacol (1976) 0.86
Drug interactions with fibric acids. Pharmacol Ther (1994) 0.85
Plasma levels and excretion of estrogens in urine in chronic lever disease. Gastroenterology (1975) 0.85
Increased production of apolipoprotein A-I associated with elevated plasma levels of high-density lipoproteins, apolipoprotein A-I, and lipoprotein A-I in a patient with familial hyperalphalipoproteinemia. Metabolism (1993) 0.85
Trimethadione tolerance test for evaluation of functional reserve of the liver in patients with liver cirrhosis and esophageal varices. J Pharmacobiodyn (1986) 0.85
Successful surgical treatment of aortogastric fistula after an esophagectomy and subsequent endovascular graft placement: report of a case. Surg Today (1999) 0.85
Inferior mesenteric and hypogastric artery reconstruction to prevent colonic ischaemia following abdominal aortic aneurysmectomy. Cardiovasc Surg (1993) 0.85
Leukotriene receptor antagonist, montelukast, can reduce the need for inhaled steroid while maintaining the clinical stability of asthmatic patients. Clin Exp Allergy (2002) 0.84
Dermal and inhalation exposure to dimethoate. Arch Environ Contam Toxicol (1992) 0.84
L-3,4-dihydroxyphenylalanine metabolism by the gut in vitro. Biochem Pharmacol (1971) 0.83
Infant exposure to environmental tobacco smoke: Jordan University hospital-based study. East Mediterr Health J (2009) 0.83
Effects of four doses of n-3 fatty acids given to hyperlipidemic patients for six months. J Am Coll Nutr (1991) 0.83
Aflatoxicol H1: a major metabolite of aflatoxin B1 produced by human and rhesus monkey livers in vitro. Res Commun Chem Pathol Pharmacol (1975) 0.83
A method for estimation of hepatic drug-metabolizing capacity: determination of concentration of trimethadione and its metabolite in human serum. J Pharmacobiodyn (1984) 0.83
Enterohepatic circulation of sulindac and metabolites. Clin Pharmacol Ther (1983) 0.83
Effects of fenofibrate on plasma lipids. Double-blind, multicenter study in patients with type IIA or IIB hyperlipidemia. Arteriosclerosis (1986) 0.83
Successful surgical treatment for spontaneous retroperitoneal hematoma in polycythemia vera: report of a case. Surg Today (2000) 0.83
Delay of ovulation by meloxicam in healthy cycling volunteers: A placebo-controlled, double-blind, crossover study. J Clin Pharmacol (2006) 0.82
Quantitation of biliary excretion of drugs in man. Clin Pharmacol Ther (1982) 0.82
Drug interactions of lipid-altering drugs. Drug Saf (1998) 0.82
Cholestyramine and spironolactone and their combination in digitoxin elimination. Clin Pharmacol Ther (1980) 0.82
Lipid-altering efficacy and safety of simvastatin 80 mg/day: worldwide long-term experience in patients with hypercholesterolemia. Nutr Metab Cardiovasc Dis (2000) 0.82
Methods to assess relative reliability of diet records: minimum records for monitoring lipid and caloric intake. J Am Diet Assoc (1986) 0.81
Effect of dimethyl sulfoxide pretreatment on activities of lipid peroxide formation, superoxide dismutase and glutathione peroxidase in the mouse liver after whole-body irradiation. J Toxicol Sci (1993) 0.81
A clinicopathological study of familial abdominal aortic aneurysms. Int Angiol (1996) 0.81
Comparison of effects of simvastatin versus atorvastatin on high-density lipoprotein cholesterol and apolipoprotein A-I levels. Am J Cardiol (2000) 0.81
Isolation of porcine adenovirus from the respiratory tract of pigs in Japan. Nihon Juigaku Zasshi (1990) 0.81
The clinical importance of conventional and quantitative liver function tests in liver transplantation. J Clin Pharm Ther (2000) 0.81
Dual hepatic metabolism of cerivastatin--clarifications. Am J Cardiol (1999) 0.81
Effects of imidazole antimycotics on the liver microsomal cytochrome P450 isoforms in rats: comparison of in vitro and ex vivo studies. Eur J Drug Metab Pharmacokinet (2001) 0.80
Effects of dietary fish oil on platelet function and plasma lipids in hyperlipoproteinemic and normal subjects. Atherosclerosis (1988) 0.80
Low- vs high-dose aspirin. Effects on platelet function in hyperlipoproteinemic and normal subjects. Arch Intern Med (1986) 0.80
The interaction between halofenate and propranolol. Clin Pharmacol Ther (1976) 0.80
Effects of a low saturated fat, low cholesterol fish oil supplement in hypertriglyceridemic patients. A placebo-controlled trial. Ann Intern Med (1988) 0.80
A two-year crossover therapeutic trial with halofenate and clofibrate. Am J Med Sci (1977) 0.80
Effects of the ACAT inhibitor CL 277,082 on cholesterol metabolism in humans. Clin Pharmacol Ther (1990) 0.80
[Retinal hazard from blue light emitting diode]. Nippon Ganka Gakkai Zasshi (2001) 0.79
Central serotonergic mechanisms on head twitch response induced by benzodiazepine receptor agonists. Pharmacology (2001) 0.79
Serum lipids in normo- and hyperlipidemics after methyldopa and propranolol. Clin Pharmacol Ther (1984) 0.79
Protective effect of dipyridamole against lethality and lipid peroxidation in liver and spleen of the ddY mouse after whole-body irradiation. Int J Radiat Biol (1996) 0.79
Casein hydrolysate formula-induced liver dysfunction in a neonate with non-immunoglobulin E-mediated cow's milk allergy. J Investig Allergol Clin Immunol (2008) 0.79
Hepatotoxicity of phenothiazines in vitro as measured by loss of aminotransferases to surrounding media. Proc Soc Exp Biol Med (1968) 0.79
Effects of local anesthetics on monoamine oxidase, and their membrane effects. Jpn J Pharmacol (1982) 0.79
In vitro testing of antioxidants and biochemical end-points in bovine retinal tissue. Ophthalmic Res (1999) 0.79
The protective effect of Clostridium novyi type B alpha-toxoid against challenge with spores in guinea pigs. J Vet Med Sci (1998) 0.79
Inhibiting cholesterol absorption with CP-88,818 (beta-tigogenin cellobioside; tiqueside): studies in normal and hyperlipidemic subjects. J Cardiovasc Pharmacol (1997) 0.79
Experimental bases for the different hepatotoxicity of erythromycin preparations in man. J Lab Clin Med (1972) 0.79
A clinical pharmacologist's view of drug hepatotoxicity. Pharmacol Res Commun (1977) 0.79
Experimental hyperlipidemia and atherosclerosis induced by cholesterol diet in SPF Japanese white rabbits. Jpn J Pharmacol (1983) 0.79
Slow-reacting and complement-requiring neutralizing antibody in swine infected with porcine reproductive and respiratory syndrome (PRRS) virus. J Vet Med Sci (1996) 0.79
[Application of microdialysis for pharmacokinetic study in rabbit anterior chamber]. Nippon Ganka Gakkai Zasshi (1995) 0.78
Erythrocytosis in thiamine deficient rats. Jpn J Pharmacol (1981) 0.78
The correlation of serum levels of two transaminases with tissue levels in six vertebrate species. Comp Biochem Physiol (1968) 0.78
Suppressive effect of basic fibroblast growth factor on transendothelial emigration of CD4(+) T-lymphocyte. Cancer Res (1994) 0.78
Efficacy and short-term safety of a new ACAT inhibitor, avasimibe, on lipids, lipoproteins, and apolipoproteins, in patients with combined hyperlipidemia. Atherosclerosis (2001) 0.78
Characteristics of reovirus type 1 from the respiratory tract of pigs in Japan. Nihon Juigaku Zasshi (1988) 0.78
Liver cell culture toxicity and surfactant potency of erythromycin derivatives. Toxicol Appl Pharmacol (1975) 0.78
Comparative clinical therapeutic trial with two hypolipidemic drugs: lofibrate and nafenopin. Clin Pharmacol Ther (1971) 0.78
Characteristics of a swine recombinant influenza virus isolated in 1980: recombination between swine and the earliest Hong Kong (H3N2) viruses. Vaccine (1985) 0.78
Suicide by xylene ingestion. A case report and review of literature. Am J Forensic Med Pathol (1986) 0.78
Hepatotoxic and cellular uptake interactions among surface active components of erythromycin preparations. Biochem Pharmacol (1978) 0.78
Probucol. Curr Atheroscler Rep (2000) 0.78
Studies on monoamine oxidase (report XXIV). Effect of harmine on monoamine oxidase. Jpn J Pharmacol (1974) 0.78